These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38979830)

  • 41. Influence of Hospital Type on Outcomes of Patients With Acute Spontaneous Intracerebral Hemorrhage: A Population-Based Study.
    Marti-Fabregas J; Ramos-Pachón A; Prats-Sanchez L; Núñez-Guillén A; Rodríguez BL; Rodriguez-Luna D; Amaro S; Silva Y; Rodriguez-Campello A; Puig I; Gomez-Choco M; Vázquez-Justes D; Guanyabens N; Cocho D; Cánovas D; Steinhauer EG; Llull L; Guasch-Jiménez M; Martinez-Domeño A; Marin R; Lambea-Gil Á; Díaz GE; Paipa-Merchan A; Quesada H; Casadevall MP; Wenger D; Pancorbo O; Seró L; Pérez J; Costa X; Zaragoza J; Rodríguez-Villatoro N; Catena E; Calvo NM; Krupinski J; De La Ossa NP; Abilleira S; Salvat-Planas M; Fagundez O; Camps-Renom P;
    Neurology; 2024 Jul; 103(2):e209539. PubMed ID: 38875516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Admission Hemoglobin Levels Are Associated With Functional Outcome in Spontaneous Intracerebral Hemorrhage.
    Acosta JN; Leasure AC; Kuohn LR; Both CP; Petersen NH; Sansing LH; Matouk CC; Testai F; Langefeld CD; Woo D; Kamel H; Murthy SB; Qureshi A; Mayer SA; Sheth KN; Falcone GJ
    Crit Care Med; 2021 May; 49(5):828-837. PubMed ID: 33591003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor-Related Atraumatic Intracerebral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care.
    Huttner HB; Gerner ST; Kuramatsu JB; Connolly SJ; Beyer-Westendorf J; Demchuk AM; Middeldorp S; Zotova E; Altevers J; Andersohn F; Christoph MJ; Yue P; Stross L; Schwab S
    Stroke; 2022 Feb; 53(2):532-543. PubMed ID: 34645283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Higher low-density lipoprotein cholesterol levels are associated with decreased mortality in patients with intracerebral hemorrhage.
    Chang JJ; Katsanos AH; Khorchid Y; Dillard K; Kerro A; Burgess LG; Goyal N; Alexandrov AW; Alexandrov AV; Tsivgoulis G
    Atherosclerosis; 2018 Feb; 269():14-20. PubMed ID: 29253643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of cerebrospinal fluid CD4+/CD8+Ratio with 60-day functional outcome after intracerebral hemorrhage.
    Zhu C; Li W; Zhang Y; Qianqian Li ; Wang H
    Int J Immunopathol Pharmacol; 2023; 37():3946320231207350. PubMed ID: 37853743
    [No Abstract]   [Full Text] [Related]  

  • 46. ABO blood type and thromboembolic complications after intracerebral hemorrhage: An exploratory analysis.
    Ironside N; Melmed K; Chen CJ; Dabhi N; Omran S; Park S; Agarwal S; Connolly ES; Claassen J; Hod EA; Roh D
    J Stroke Cerebrovasc Dis; 2024 May; 33(5):107678. PubMed ID: 38479493
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum secretoneurin as a promising biomarker for predicting poor prognosis in intracerebral hemorrhage: A prospective cohort study.
    Zhu X; Shan H; Wang Z; Wang Y; Yan T; Chen Z; Zhang X
    Neurosurg Rev; 2024 Jul; 47(1):320. PubMed ID: 39002049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic Significance of Hyperglycemia in Acute Intracerebral Hemorrhage: The INTERACT2 Study.
    Saxena A; Anderson CS; Wang X; Sato S; Arima H; Chan E; Muñoz-Venturelli P; Delcourt C; Robinson T; Stapf C; Lavados PM; Wang J; Neal B; Chalmers J; Heeley E;
    Stroke; 2016 Mar; 47(3):682-8. PubMed ID: 26814235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low hemoglobin is associated with worse outcomes via larger hematoma volume in intracerebral hemorrhage due to systemic disease.
    Zhang S; Shu Y; Chen Y; Liu X; Liu Y; Cheng Y; Wu B; Lei P; Liu M
    MedComm (2020); 2022 Mar; 3(1):e96. PubMed ID: 35281786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A troponin study on patients with ischemic stroke, intracerebral hemorrhage and subarachnoid hemorrhage: Type II myocardial infarction is significantly associated with stroke severity, discharge disposition and mortality.
    Alkhachroum AM; Miller B; Chami T; Tatsuoka C; Sila C
    J Clin Neurosci; 2019 Jun; 64():83-88. PubMed ID: 31014907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemoglobin Concentration Impacts Viscoelastic Hemostatic Assays in ICU Admitted Patients.
    Roh DJ; Chang TR; Kumar A; Burke D; Torres G; Xu K; Yang W; Cottarelli A; Moore E; Sauaia A; Hansen K; Velazquez A; Boehme A; Vrosgou A; Ghoshal S; Park S; Agarwal S; Claassen J; Connolly ES; Wagener G; Francis RO; Hod E
    Crit Care Med; 2023 Feb; 51(2):267-278. PubMed ID: 36661453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods.
    Yeatts SD; Palesch YY; Moy CS; Selim M
    Neurocrit Care; 2013 Oct; 19(2):257-66. PubMed ID: 23943316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Iron chelation suppresses secondary bleeding after intracerebral hemorrhage in angiotensin II-infused mice.
    Wang J; Tang XQ; Xia M; Li CC; Guo C; Ge HF; Yin Y; Wang B; Chen WX; Feng H
    CNS Neurosci Ther; 2021 Nov; 27(11):1327-1338. PubMed ID: 34346561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perihematomal Edema and Functional Outcomes in Intracerebral Hemorrhage: Influence of Hematoma Volume and Location.
    Murthy SB; Moradiya Y; Dawson J; Lees KR; Hanley DF; Ziai WC;
    Stroke; 2015 Nov; 46(11):3088-92. PubMed ID: 26396030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early deterioration of iron status among a cohort of Bolivian infants.
    Burke RM; Rebolledo PA; Fabiszewski de Aceituno AM; Revollo R; Iñiguez V; Klein M; Drews-Botsch C; Leon JS; Suchdev PS
    Matern Child Nutr; 2017 Oct; 13(4):. PubMed ID: 27928891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alterations in inflammatory markers and clinical outcome after spontaneous intracerebral hemorrhage - Preliminary results.
    Müller M; Tapia-Perez JH; Yildiz C; Rashidi A; Luchtmann M
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104861. PubMed ID: 32430234
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors.
    Leira R; Dávalos A; Silva Y; Gil-Peralta A; Tejada J; Garcia M; Castillo J;
    Neurology; 2004 Aug; 63(3):461-7. PubMed ID: 15304576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of Statins on Hematoma, Edema, Seizures, Vascular Events, and Functional Recovery After Intracerebral Hemorrhage.
    Sprügel MI; Kuramatsu JB; Volbers B; Saam JI; Sembill JA; Gerner ST; Balk S; Hamer HM; Lücking H; Hölter P; Nolte CH; Scheitz JF; Rocco A; Endres M; Huttner HB
    Stroke; 2021 Mar; 52(3):975-984. PubMed ID: 33517701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Deferoxamine on Outcome According to Baseline Hematoma Volume: A Post Hoc Analysis of the i-DEF Trial.
    Wei C; Wang J; Foster LD; Yeatts SD; Moy C; Mocco J; Selim M;
    Stroke; 2022 Apr; 53(4):1149-1156. PubMed ID: 34789008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Recombinant Activated Coagulation Factor VII on Hemorrhage Expansion Among Patients With Spot Sign-Positive Acute Intracerebral Hemorrhage: The SPOTLIGHT and STOP-IT Randomized Clinical Trials.
    Gladstone DJ; Aviv RI; Demchuk AM; Hill MD; Thorpe KE; Khoury JC; Sucharew HJ; Al-Ajlan F; Butcher K; Dowlatshahi D; Gubitz G; De Masi S; Hall J; Gregg D; Mamdani M; Shamy M; Swartz RH; Del Campo CM; Cucchiara B; Panagos P; Goldstein JN; Carrozzella J; Jauch EC; Broderick JP; Flaherty ML;
    JAMA Neurol; 2019 Dec; 76(12):1493-1501. PubMed ID: 31424491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.